Table 1.
Baseline and procedure characteristics
| DEMOGRAPHICS | mean ± SD or % |
|---|---|
| Age, years | 74.9 ± 10.6 |
| Female | 68.7% |
| COMORBIDITIES | |
| STS PROM % | 6.3 ± 5.3 |
| Surgical risk | |
| Low | 4.7% |
| Intermediate | 28.2% |
| High | 54.0% |
| Extreme | 13.1% |
| Aortic lesion | |
| Aortic stenosis | 85.9% |
| Aortic regurgitation | 14.1% |
| Aortic valve | |
| Native | 27.2% |
| Bioprosthetic | 72.8% |
| Prior stroke | 14.6% |
| Prior CABG | 31.6% |
| PROCEDURE | Mean ± SD or % |
| Valve type | |
| Sapien 3 | 60.1% |
| Evolut R/Pro | 39.9% |
| Nominal valve size, mm | 23.5 ± 2.3 |
| Access for TAVR | |
| Transfemoral | 91.1% |
| Transcaval | 7.0% |
| Subclavian/Axillary | 0.9% |
| Carotid | 0.9% |
| Target cusp | |
| Left solo | 68.7% |
| Right solo | 9.8% |
| Doppio | 21.5% |
| Sentinel cerebral protection | 47.7% |